Please use this identifier to cite or link to this item:
Title: Rates and predictors of hypoglycaemia in 27 585 people from 24 countries with insulin-treated type 1 and type 2 diabetes: the global HAT study.
Authors: Khunti, K.
Alsifri, S.
Aronson, R.
Cigrovski Berković, M.
Enters-Weijnen, C.
Forsén, T.
Galstyan, G.
Geelhoed-Duijvestijn, P.
Goldfracht, M.
Gydesen, H.
Kapur, R.
Lalic, N.
Ludvik, B.
Moberg, E.
Pedersen-Bjergaard, U.
Ramachandran, A.
HAT Investigator Group
First Published: 20-Jun-2016
Publisher: Wiley
Citation: Diabetes, Obesity and Metabolism, 2016, 18 (9), pp. 907-915
Abstract: AIMS: To determine the global extent of hypoglycaemia experienced by patients with diabetes using insulin, as there is a lack of data on the prevalence of hypoglycaemia in developed and developing countries. METHODS: This non-interventional, multicentre, 6-month retrospective and 4-week prospective study using self-assessment questionnaire and patient diaries included 27 585 patients, aged ≥18 years, with type 1 diabetes (T1D; n = 8022) or type 2 diabetes (T2D; n = 19 563) treated with insulin for >12 months, at 2004 sites in 24 countries worldwide. The primary endpoint was the proportion of patients experiencing at least one hypoglycaemic event during the observational period. RESULTS: During the prospective period, 83.0% of patients with T1D and 46.5% of patients with T2D reported hypoglycaemia. Rates of any, nocturnal and severe hypoglycaemia were 73.3 [95% confidence interval (CI) 72.6-74.0], 11.3 (95% CI 11.0-11.6) and 4.9 (95% CI 4.7-5.1) events/patient-year for T1D and 19.3 (95% CI 19.1-19.6), 3.7 (95% CI 3.6-3.8) and 2.5 events/patient-year (95% CI 2.4-2.5) for T2D, respectively. The highest rates of any hypoglycaemia were observed in Latin America for T1D and Russia for T2D. Glycated haemoglobin level was not a significant predictor of hypoglycaemia. CONCLUSIONS: We report hypoglycaemia rates in a global population, including those in countries without previous data. Overall hypoglycaemia rates were high, with large variations between geographical regions. Further investigation into these differences may help to optimize therapy and reduce the risk of hypoglycaemia.
DOI Link: 10.1111/dom.12689
ISSN: 1462-8902
eISSN: 1463-1326
Version: Publisher Version
Status: Peer-reviewed
Type: Journal Article
Rights: © 2016 The Authors. Diabetes, Obesity and Metabolism published by John Wiley & Sons Ltd. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
Description: Additional Supporting Information may be found in the online version of this article: File S1. Patient disposition by country. File S2. Baseline characteristics by region of patients with type 1 diabetes. Table S1. Patient disposition by country. Table S2. Baseline characteristics by region of patients with type 1 diabetes. Table S3. Baseline characteristics by region of patients with type 2 diabetes. Table S4. Severe hypoglycaemia rates during the prospective period by geographic region.
Appears in Collections:Published Articles, Dept. of Health Sciences

Files in This Item:
File Description SizeFormat 
Khunti_et_al-2016-Diabetes,_Obesity_and_Metabolism.pdfPublished (publisher PDF)622.4 kBAdobe PDFView/Open

Items in LRA are protected by copyright, with all rights reserved, unless otherwise indicated.